SpaceX (SPCX) Stock Is Plunging. Should You Buy the Dip?

SpaceX shares fell nearly 20% over the past week and briefly dropped below their $150 IPO price, reversing an initial 67% surge from the June 12 debut. The article argues the stock is still wildly overvalued at a 77 price-to-sales ratio, with no profits, significant dilution risk, and $25 billion already raised via debt. Overall, it frames SpaceX as a high-risk, priced-for-perfection IPO with limited margin of safety.

Analysis

The market is extrapolating a venture-style growth asset into a public-market multiple without the normal discipline of dilution, funding cadence, and forward cash generation. That setup tends to work until it doesn’t: the first crack is usually not revenue growth, but a change in the financing narrative, where incremental capital starts to matter more than unit economics. If the company keeps leaning on debt and equity as a quasi-public private-market vehicle, the implied terminal margin and terminal scale assumptions become less relevant than the cost of capital, which can compress valuation far faster than operating results would suggest.

Second-order winners are the obvious public-market proxies for the same thematic exposure: the article’s mention of NVDA and MU is useful only insofar as it highlights investor willingness to pay up for infrastructure beneficiaries with visible earnings, not moonshot cash burn. In a risk-off rotation, capital is more likely to reprice into profitable enablers and picks-and-shovels rather than the asset with the most convex headline beta. NFLX is a weaker read-through, but the broader signal is that investors may be rotating away from long-duration narrative assets and back toward self-funding compounders.

The key catalyst is not the next operational milestone; it’s any indication that financing becomes more constrained or more expensive over the next 3-12 months. A secondary catalyst is lockup-style supply or insider monetization, which can create air pockets when momentum investors realize the float behaves more like a late-stage private round than a normal public equity. Conversely, the bearish case weakens only if management proves durable cash generation before the capital stack needs another reset.

The consensus may be underestimating how much of the current valuation is supported by scarcity and optionality rather than fundamentals. That does not mean the move is immediately shortable on timing alone, but it does mean the downside is likely to come in discontinuous gaps rather than a smooth drift. In that regime, the best trades are those that benefit from a repricing of duration and financing risk, not just a reversal in sentiment.

Key Decisions for Investors

• Avoid initiating new longs in the stock; if forced to express a view, use put spreads 3-6 months out to capture a valuation reset tied to financing headlines rather than daily volatility.
• Relative-value long NVDA / short the speculative IPO exposure basket for 1-3 months: own cash-generative AI infrastructure while fading the most duration-sensitive narrative premium.
• On pullbacks driven by the next capital-raising rumor, sell into strength rather than averaging down; the risk/reward is asymmetrically negative once the market starts discounting another financing round within 6-12 months.
• For hedged accounts, consider a short via options only, sized small, because squeeze risk remains high while the float is still dominated by momentum and private-market optics.
• Monitor debt issuance and any equity-linked financing language closely; if new capital comes at a meaningfully higher cost, add to bearish exposure because multiple compression would likely precede any operational deterioration.